CHP Merger filed an investor presentation with the SEC, highligting its proposed merger with Integrity Implants d/b/a Accelus. The deal gives the merged companies an enterprise value of $482 million.
Funding includes the $300 million held in the SPAC’s trust, as well as $414 million in Accelus rollover equity, according to a slide deck (p. 34).
Based in Palm Beach Gardens, Florida, and established through the combination of Integrity Implants and Fusion Robotics, Accelus is a commercial stage medical technology company aiming to accelerate the adoption of minimally invasive surgery. Read more.
